Latest Underwriting News

PYC Therapeutics has launched a A$653 million capital raising to fund the clinical advancement of four RNA-based drug candidates targeting genetic diseases with significant unmet needs. The raise extends the company’s cash runway to 2030, supporting key clinical milestones and a transition to commercialisation.

PYC Therapeutics has launched a substantial $653 million equity raise to fund clinical trials for four promising drug candidates targeting genetic diseases. This capital injection aims to advance the company’s pipeline through critical human efficacy milestones.

ClearVue Technologies advances its building-integrated solar tech with new product breakthroughs and global commercial projects, while strengthening its financial footing and board expertise.

Mount Ridley Mines has reported maiden JORC mineral resource estimates for scandium and gallium at its Mount Ridley Project, significantly boosting its critical minerals portfolio and consolidating tenure across a 70-kilometre strike.

Identitii Limited has secured five new customer contracts worth $250k and seen a four-fold increase in usage of its BNDRY platform, even as its capital raising efforts face delays due to a Takeovers Panel application.

Central Petroleum has secured a letter of intent for a long-term gas supply contract through 2034 and expanded its exploration portfolio into the Otway and Cooper Basins, setting the stage for multiple new wells and production growth.

Biotron Limited has completed the acquisition of Sedarex Limited alongside a $2.5 million capital raising, while its lead Hepatitis B drug candidate BIT-HBV001 shows promising preclinical results outperforming current treatments.

29Metals Limited has initiated a fully underwritten $150 million entitlement offer at $0.40 per share, aiming to bolster its growth projects and operational recovery following seismic disruptions. The retail offer opens on 28 January and closes on 11 February 2026.

Advanced Metals has ramped up its drilling programs in Mexico and Australia, backed by a $13 million capital raise and strengthened leadership, positioning itself for significant resource growth in 2026.

AUB Group Limited has announced the acquisition of a 95.9% stake in UK-based PIHL Holdings Limited (Prestige) for AUD 432 million, significantly expanding its UK retail insurance broking footprint. To fund this strategic move, AUB is launching a fully underwritten AUD 400 million institutional placement alongside a share purchase plan.

Nova Minerals has secured US$43.4 million in non-dilutive funding from the U.S. Department of War to fully fund its domestic antimony supply chain development in Alaska, while also progressing its vast Estelle gold project with promising drilling results.

Assetora Limited has announced a $4 million pro-rata rights issue priced at $0.16 per share, with half the offer underwritten by existing shareholders to strengthen its balance sheet and repay debt.